IL88961A - Stable mixtures containing oxidation-sensitive compounds - Google Patents

Stable mixtures containing oxidation-sensitive compounds

Info

Publication number
IL88961A
IL88961A IL88961A IL8896189A IL88961A IL 88961 A IL88961 A IL 88961A IL 88961 A IL88961 A IL 88961A IL 8896189 A IL8896189 A IL 8896189A IL 88961 A IL88961 A IL 88961A
Authority
IL
Israel
Prior art keywords
mixtures containing
sensitive compounds
containing oxidation
stable mixtures
stable
Prior art date
Application number
IL88961A
Other languages
English (en)
Other versions
IL88961A0 (en
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL88961A0 publication Critical patent/IL88961A0/xx
Publication of IL88961A publication Critical patent/IL88961A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00Anti-oxidant compositions; Compositions inhibiting chemical change
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
IL88961A 1988-01-29 1989-01-16 Stable mixtures containing oxidation-sensitive compounds IL88961A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1723288 1988-01-29

Publications (2)

Publication Number Publication Date
IL88961A0 IL88961A0 (en) 1989-08-15
IL88961A true IL88961A (en) 1992-07-15

Family

ID=11938201

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88961A IL88961A (en) 1988-01-29 1989-01-16 Stable mixtures containing oxidation-sensitive compounds

Country Status (10)

Country Link
US (1) US4929774A (xx)
EP (1) EP0326026B1 (xx)
KR (1) KR890011974A (xx)
CN (1) CN1023229C (xx)
CA (1) CA1331136C (xx)
DE (1) DE58901641D1 (xx)
DK (1) DK174663B1 (xx)
IL (1) IL88961A (xx)
IN (1) IN171845B (xx)
SU (1) SU1639425A3 (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610626B1 (fr) * 1987-02-09 1989-05-19 Oreal Nouveau systeme anti-oxydant a base d'un ester d'ascorbyle stabilise, contenant en association au moins un agent complexant et au moins un thiol, et compositions contenant un tel systeme anti-oxydant
JPH02124894A (ja) * 1988-11-01 1990-05-14 Sanwa Kagaku Kenkyusho Co Ltd フィチン酸安定化組成物
US5180747A (en) * 1989-02-28 1993-01-19 Nisshin Flour Milling Co., Ltd. Stabilized fat-soluble vitamin compositions
US5290605A (en) * 1989-06-29 1994-03-01 Niva Shapira Sun-exposure nutritional supporting composition
KR930006431B1 (ko) * 1990-10-11 1993-07-16 재단법인 한국화학연구소 약물의 미세캡슐화 방법
ES2221921T3 (es) * 1992-07-13 2005-01-16 Shiseido Company, Ltd. Composicion para preparacion dermatologica.
US5270063A (en) * 1992-08-03 1993-12-14 Kellogg Company Ready-to-eat cereal products enriched with beta-carotene
FR2703263B1 (fr) * 1993-03-31 1995-05-19 Rhone Poulenc Nutrition Animal Procédé de préparation de sphérules de principes actifs.
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
JPH07203950A (ja) * 1994-01-26 1995-08-08 Kanegafuchi Chem Ind Co Ltd 被覆されたファフィア・ロドチーマ酵母及びその造粒物
AUPM677594A0 (en) * 1994-07-12 1994-08-04 Daratech Pty Ltd Preservation of exposed underground plant structures
JPH11503023A (ja) * 1995-04-07 1999-03-23 アボット・ラボラトリーズ ビタミンdを含有するカルシウム補給剤およびカルシウム含有飲料
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
DE19518845A1 (de) * 1995-05-23 1996-11-28 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Phytinsäure
US5827904A (en) * 1996-09-27 1998-10-27 Hahn; David Medical implant composition
EP0984915A4 (en) 1997-04-04 2002-11-27 Henkel Corp LUTEINE ESTERS WITH HIGH BIOAVAILABILITY
US6007856A (en) * 1997-08-08 1999-12-28 The Procter & Gamble Company Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
US20020068090A1 (en) * 1999-02-03 2002-06-06 Bell Steve J. D. Calcium phosphate particles as mucosal adjuvants
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
US6355271B1 (en) 1999-02-03 2002-03-12 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of manufacture and use
US6328995B1 (en) * 1999-09-24 2001-12-11 Basf Aktiengesellschaft Stable vitamin and/or carotenoid products in powder form and process for their production
JP4227409B2 (ja) * 2001-01-30 2009-02-18 サビンサ コーポレーション 安定なルテインおよびルテイン誘導体の組成物を得るためのプロセス
US20060062855A1 (en) * 2001-02-27 2006-03-23 Bell Steve J D Therapeutic calcium phosphate particles for use in inhibiting expression of a gene
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
DE10300325A1 (de) 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
JP2006516396A (ja) 2003-01-31 2006-07-06 デーエスエム アイピー アセッツ ベー. ヴェー. カロテノイドを含む新規な組成物
DE10311585A1 (de) 2003-03-14 2004-09-23 Basf Ag Wirkstoffhaltige Adsorbate
DE10325989A1 (de) * 2003-06-07 2005-01-05 Glatt Gmbh Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
US7446101B1 (en) * 2003-12-12 2008-11-04 Bioactives, Llc Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems
US9247765B2 (en) * 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
CN1933850B (zh) 2004-03-22 2011-01-12 索尔瓦药物有限公司 含表面活性剂的、含脂肪酶产品尤其是胰酶的口服药物组合物
US7351424B2 (en) * 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same
TWI309984B (en) * 2004-07-30 2009-05-21 Wakunaga Pharma Co Ltd Composition for capsule coating, capsule coating, and capsule agent
EP1811941A4 (en) 2004-11-01 2008-09-10 Biosante Pharmaceuticals Inc CALCIUM PHOSPHATE THERAPEUTIC PARTICLES FOR AESTHETIC OR COSMETIC MEDICINE, AND METHODS OF MAKING AND USING THE SAME
EP1913138B1 (en) 2005-07-29 2016-08-24 Abbott Laboratories GmbH Processes for the manufacture of pancreatin powder with low virus content
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20070065487A1 (en) * 2005-09-21 2007-03-22 Bio Lut S.A. De C.V. Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
JP6954917B2 (ja) * 2016-03-24 2021-10-27 ビーエイエスエフ・ソシエタス・エウロパエアBasf Se 多相活性物質調製物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5614338B2 (xx) * 1973-05-31 1981-04-03
DE3135329A1 (de) * 1981-09-05 1983-03-24 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von trockenpulvern oxidationsempfindlicher substanzen
JPS59122424A (ja) * 1982-12-29 1984-07-14 Riken Vitamin Co Ltd ビタミンa組成物およびその製造法
JPS59204696A (ja) * 1983-05-06 1984-11-20 三井製薬工業株式会社 酸化防止剤
JPS62111676A (ja) * 1985-11-12 1987-05-22 Nippon Oil & Fats Co Ltd 酸化防止製剤

Also Published As

Publication number Publication date
DK35589D0 (da) 1989-01-27
IL88961A0 (en) 1989-08-15
EP0326026A3 (en) 1990-11-14
EP0326026B1 (de) 1992-06-17
KR890011974A (ko) 1989-08-23
SU1639425A3 (ru) 1991-03-30
EP0326026A2 (de) 1989-08-02
CN1036220A (zh) 1989-10-11
CA1331136C (en) 1994-08-02
DE58901641D1 (de) 1992-07-23
IN171845B (xx) 1993-01-23
DK35589A (da) 1989-07-30
DK174663B1 (da) 2003-08-18
CN1023229C (zh) 1993-12-22
US4929774A (en) 1990-05-29

Similar Documents

Publication Publication Date Title
IL88961A0 (en) Stable mixtures containing oxidation-sensitive compounds
GB8801646D0 (en) Chemical compounds
GB8808015D0 (en) Chemical compounds
GB8804104D0 (en) Chemical compounds
GB8808138D0 (en) Chemical compounds
GB2223224B (en) Chemical compounds
GB8807275D0 (en) Chemical compounds
GB8802127D0 (en) Chemical compounds
GB8801908D0 (en) Chemical compounds
GB8810185D0 (en) Chemical compounds
GB8808085D0 (en) Chemical compounds
GB8804703D0 (en) Chemical compounds
GB8809466D0 (en) Chemical compounds
GB8809467D0 (en) Chemical compounds
GB8809730D0 (en) Chemical compounds
GB8809332D0 (en) Chemical compounds
GB8809731D0 (en) Chemical compounds
GB8809837D0 (en) Chemical compounds
GB8804108D0 (en) Chemical compounds
GB8808086D0 (en) Chemical compounds
GB8809901D0 (en) Chemical compounds
GB8808931D0 (en) Chemical compounds
GB8809902D0 (en) Chemical compounds
GB8808139D0 (en) Chemical compounds
GB8800552D0 (en) Chemical compounds

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees